New ELISA Blood Test Offers Important Insights to Patients with Scleroderma and Systemic Sclerosis
The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with scleroderma and associated with gastrointestinal complications. This suggests a link between scleroderma and the gut microbiome, a finding […]